Arkolith/Insider Trading/ACRX/Form 4

Asadorian Raffi

Chief Financial OfficerACELRX PHARMACEUTICALS INC (ACRX) · full profile →Form 4 · filed Feb 14, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 11, 2023Tax withholding(F)873$1.68$1K23K
Feb 10, 2023Grant(A)6K—$023K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 10, 2023Grant(A)35K—$035K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-009123) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML